Sanofi-Cathay Pharmaceutical Innovation Fund
Sanofi-Cathay Pharmaceutical Innovation Fund is a fund managed by Cathay Capital and Sanofi, a global French-based pharmaceutical company. The fund aims to support Chinese pharmaceutical companies in advancing their clinical-stage pipeline drugs. It seeks to facilitate the transition from research and development (R&D) to commercialization, thereby accelerating access to global markets for these innovations. By leveraging Sanofi's extensive experience in drug development and commercialization, the fund intends to enhance the capabilities of its portfolio companies, helping them navigate regulatory challenges and optimize their market strategies.